Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial.

about

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial.

Item

http://www.wikidata.org/entity/Q52590747

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@en

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@nl

type

Item

label

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@en

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@nl

prefLabel

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@en

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@nl

P1476

Effectiveness of gliclazide MR ...... alyses from the EASYDia trial.

@en

P2093

Ilhan Satman

http://www.w3.org/2001/XMLSchema#string

Lawrence A Leiter

http://www.w3.org/2001/XMLSchema#string

Marina V Shestakova

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.

Recommendations for management of diabetes during Ramadan: update 2015.

P2888

s13098-018-0331-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-018-0331-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103149104

http://www.w3.org/2001/XMLSchema#string

P698

29651307

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5894204

http://www.w3.org/2001/XMLSchema#string